On Monday, June 16, 2003 Guidant announced plans to stop making the ANCURE® ENDOGRAFT® System product line. This system is used to treat abdominal aortic aneurysms (AAA).
Patients implanted with the system are not at risk as a result of this decision. The long-term safety and efficacy of the system have been well documented.
Patients should continue with routine medical care and follow-up visits to their doctors.
Guidant will continue to support doctors and patients with this system. We will support physicians implanting the ANCURE System through October 1, 2003. After that date, we will provide information for long-term patient follow-up and device tracking.
Phone: 1-888-575-9646
Fax: 1-800-728-1213
Email: ancure@guidant.com
Mail: 4100 Hamline Ave. N, F235, Saint Paul, MN 55112-5798